Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. Mid-cap ...
At Limitless Evolution, we focus on restoring function instead of masking symptoms. ReGen Medical RCT helps us support real healing with non-surgical, drug-free technology that works with the body.” — ...
ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
In a deal that might as well be termed a heart-to-heart, Shockwave Medical has made a bid to combine Neovasc’s cardiac device business with its own. Shockwave has offered up $27.25 in upfront cash for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results